Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update
Top Cited Papers
Open Access
- 13 June 2018
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 8, 211
- https://doi.org/10.3389/fonc.2018.00211
Abstract
The Epstein–Barr virus (EBV) is a DNA lymphotropic herpesvirus and the causative agent of infectious mononucleosis. EBV is highly prevalent since it affects more than 90% of individuals worldwide, and has been linked to several malignancies including PTLDs, which are one of the most common malignancies following transplantation. Among all the EBV genes, most of the recent investigations focused on studying the LMP-1 oncogene because of its high degree of polymorphism and association with tumorigenic activity. There are two main EBV genotypes, Type 1 and 2, distinguished by the differences in the EBNA-2 gene. Further sub genotyping can be characterized by analyzing the LMP-1 gene variation. The virus primarly transmitts through oral secretions, and persists as a latent infection in human B-cells. However, it can be transmitted through organ transplantations and blood transfusions. In addition, symptoms of EBV infection are not distinguishable from other viral infections and therefore, it remains questionable whether there is a need to screen for EBV prior to blood transfusion. Although the process of leukoreduction decreases the viral copies present in the leukocytes, it does not eliminate the risk of EBV transmission through blood products. Here, we provide a review of the EBV epidemiology and the genetic variability of the oncogene LMP1. Then we underscore the findings of recent EBV seroprevalence and viremia studies among blood donors as a highly prevalent transfusion transmissible oncovirus.Keywords
Funding Information
- Qatar National Research Fund (UREP18-001-3-001)
- Qatar University (QUCG-CHS-2018\2019-1)
This publication has 156 references indexed in Scilit:
- Seroprevalence of Epstein-Barr Virus Infection in U.S. Children Ages 6-19, 2003-2010PLOS ONE, 2013
- Is There Diagnostic Value in Detection of Immunoglobulin G Antibodies to the Epstein–Barr Virus Early Antigen?BioResearch Open Access, 2012
- Epstein-Barr Virus Sequence Variation—Biology and DiseasePathogens, 2012
- Epstein–Barr virus and Hodgkin’s lymphoma in Cairo, EgyptJournal of Hematopathology, 2010
- Using Epstein-Barr Viral Load Assays To Diagnose, Monitor, and Prevent Posttransplant Lymphoproliferative DisorderClinical Microbiology Reviews, 2010
- A review of human carcinogens—Part B: biological agentsPublished by Elsevier BV ,2009
- Acute Parvovirus B19 Infection Frequently Causes False-Positive Results in Epstein-Barr Virus- and Herpes Simplex Virus-Specific Immunoglobulin M Determinations Done on the Liaison PlatformClinical and Vaccine Immunology, 2009
- Resting B cells as a transfer vehicle for Epstein–Barr virus infection of epithelial cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- LMP1 structure and signal transductionSeminars in Cancer Biology, 2001
- VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMAThe Lancet, 1964